A detailed history of Xtx Topco LTD transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 125,847 shares of INMB stock, worth $304,549. This represents 0.01% of its overall portfolio holdings.

Number of Shares
125,847
Previous 36,919 240.87%
Holding current value
$304,549
Previous $288,000 0.69%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

BUY
$2.31 - $8.26 $205,423 - $734,545
88,928 Added 240.87%
125,847 $290,000
Q1 2025

May 07, 2025

SELL
$4.93 - $10.48 $120,055 - $255,208
-24,352 Reduced 39.74%
36,919 $288,000
Q4 2024

Feb 13, 2025

BUY
$4.4 - $6.43 $66,079 - $96,565
15,018 Added 32.47%
61,271 $286,000
Q3 2024

Nov 14, 2024

BUY
$4.86 - $9.86 $224,789 - $456,054
46,253 New
46,253 $249,000

Others Institutions Holding INMB

About Inmune Bio, Inc.


  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $43.4M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.